University of Groningen
The tooth of time
Barends, Clemens
DOI:
10.33612/diss.149628817
IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from
it. Please check the document version below.
Document Version
Publisher's PDF, also known as Version of record
Publication date:
2021
Link to publication in University of Groningen/UMCG research database
Citation for published version (APA):
Barends, C. (2021). The tooth of time: Procedural sedation in nursing homes for frail, elderly patients.
University of Groningen. https://doi.org/10.33612/diss.149628817
Copyright
Other than for strictly personal use, it is not permitted to download or to forward/distribute the text or part of it without the consent of the author(s) and/or copyright holder(s), unless the work is under an open content license (like Creative Commons).
Take-down policy
If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately and investigate your claim.
Downloaded from the University of Groningen/UMCG research database (Pure): http://www.rug.nl/research/portal. For technical reasons the number of authors shown on this cover page is limited to 10 maximum.
CHAPTER 11
131 References
1. Fry S. QI season 10 episode 6, “Joints”. aired 19th October 2012. , Available from https://youtu.be/5G6-Gb2vq3g (05/26 2020).
2. WHO . Dementia. 2019, Available from https://www.who.int/news-room/fact-sheets/ detail/dementia (4/12 2020).
3. Alzheimer Nederland. Factsheet alzheimer. 2017, Available from https://www. alzheimer-nederland.nl/sites/default/files/directupload/factsheet-dementie-algemeen.pdf (08/07 2018).
4. CBS. Dementia oorzaak een op de tien sterfgevallen. 2017, Available from https:// www.cbs.nl/nl-nl/nieuws/2017/29/dementie-oorzaak-een-op-de-tien-sterfgevallen (05/26 2020).
5. Poos M, Gijsen R, van Bommel H. Dementie, cijfers & context, huidige situatie. , Available from https://www.volksgezondheidenzorg.info/onderwerp/dementie/cijfers-context/huidige-situatie#node-aantal-personen-met-dementie-de-bevolking (05/26 2020).
6. Hoeksema AR, Vissink A, Raghoebar GM, et al. Oral health in care-dependent elderly:
An inventory in a nursing home in the north of the netherlands. Ned Tijdschr Tandheelkd 2014; 121(12): 627-33.
7. Noble JM, Scarmeas N, Papapanou PN. Poor oral health as a chronic, potentially modifiable dementia risk factor: Review of the literature. Current Neurology and
Neuroscience Reports 2013; 13(10): 384.
8. Delwel S, Binnekade TT, Perez RS, Hertogh CM, Scherder EJ, Lobbezoo F. Oral health and orofacial pain in older people with dementia: A systematic review with focus on dental hard tissues. Clin Oral Investig 2017; 21(1): 17-32.
9. Cohen-Mansfield J, Lipson S. The underdetection of pain of dental etiology in persons with dementia. Am J Alzheimers Dis Other Demen 2002; 17(4): 249-53.
10. Chen X, Clark JJ, Naorungroj S. Oral health in nursing home residents with different cognitive statuses. Gerodontology 2013; 30(1): 49-60.
11. Lobbezoo F, Weijenberg RA, Scherder EJ. Topical review: Orofacial pain in dementia patients. A diagnostic challenge. J Orofac Pain 2011; 25(1): 6-14.
12. Demmer RT, Norby FL, Lakshminarayan K, et al. Periodontal disease and incident
dementia: The atherosclerosis risk in communities study (ARIC). Neurology 2020;. 13. Rolim Tde S, Fabri GM, Nitrini R, et al. Evaluation of patients with alzheimer’s disease
before and after dental treatment. Arq Neuropsiquiatr 2014; 72(12): 919-24.
14. Müller F, Shimazaki Y, Kahabuka F, Schimmel M. Oral health for an ageing population: The importance of a natural dentition in older adults. Int Dent J 2017; 67: 7-13. 15. Delwel S, Scherder EJA, de Baat C, et al. Orofacial pain and its potential oral causes in
older people with mild cognitive impairment or dementia. J Oral Rehabil 2019; 46(1): 23-32.
16. Tonsekar PP, Jiang SS, Yue G. Periodontal disease, tooth loss and dementia: Is there a link? A systematic review. Gerodontology 2017; 34(2): 151-63.
17. Desai AK, Grossberg GT. Recognition and management of behavioral disturbances in dementia. Prim Care Companion J Clin Psychiatry 2001; 3(3): 93-109.
References Chapter 11
18. Chalmers JM, Levy SM, Buckwalter KC, Ettinger RL, Kambhu PP. Factors influencing nurses’ aides’ provision of oral care for nursing facility residents. Special Care in Dentistry 1996; 16(2): 71-9.
19. Bridges‐Parlet S, Knopman D, Thompson T. A descriptive study of physically aggressive behavior in dementia by direct observation. J Am Geriatr Soc 1994; 42(2): 192-7. 20. Ministerie van VWS. Dwang in de zorg > wet zorg en dwang. 2020, Available from
https://www.dwangindezorg.nl/wzd (06/06 2020).
21. Ministerie van VWS. Wet zorg en dwang psychogeriatrische en verstandelijk gehandicapte cliënten. 2020, Available from https://www.dwangindezorg.nl/binaries/ dwangindezorg/documenten/publicaties/implementatie/wzd/diversen/integrale-wetstekst-wzd-incl-aanpassingswet/Wet+zorg+en+dwang.pdf (06/06 2020). 22. de Souza Rolim T, Fabri GMC, Nitrini R, et al. Oral infections and orofacial pain in
alzheimer’s disease: A case-control study. J Alzheimer’s Dis 2014; 38(4): 823-9. 23. Jablonski RA, Therrien B, Kolanowski A. No more fighting and biting during mouth care:
Applying the theoretical constructs of threat perception to clinical practice. Research
and Theory for Nursing Practice 2011; 25(3): 163-75.
24. Jablonski RA, Kolanowski A, Therrien B, Mahoney EK, Kassab C, Leslie DL. Reducing care-resistant behaviors during oral hygiene in persons with dementia. BMC Oral Health 2011; 11(1): 30.
25. ASA Committee on Quality Management and Departmental Administration. Continuum of depth of sedation: Definition of general anesthesia and levels of Sedation/Analgesia. 2019, Available from https://www.asahq.org/standards-and-guidelines/continuum-of-depth-of-sedation-definition-of-general-anesthesia-and-levels-of-sedationanalgesia (06/29 2020).
26. Cao X, White PF, Ma H. Perioperative care of elderly surgical outpatients. Drugs Aging 2017; 34(9): 673-89.
27. Buigues C, Juarros-Folgado P, Fernández-Garrido J, Navarro-Martínez R, Cauli O. Frailty syndrome and pre-operative risk evaluation: A systematic review. Arch Gerontol
Geriatr 2015; 61(3): 309-21.
28. Shem Tov L, Matot I. Frailty and anesthesia. Curr Opin Anaesthesiol 2017; 30(3): 409-17.
29. Thurmann PA. Pharmacodynamics and pharmacokinetics in older adults. Curr Opin Anaesthesiol 2020; 33(1): 109-13.
30. Fried LP, Tangen CM, Walston J, et al. Frailty in older adults: Evidence for a phenotype. The Journals of Gerontology Series A: Biological Sciences and Medical Sciences 2001; 56(3):
M146-57.
31. Whitlock E, Whittington RA. Geriatric anesthesia, an issue of anesthesiology clinics E-bookElsevier Health Sciences, 2019.
32. Bell GD, Spickett GP, Reeve PA, Morden A, Logan RF. Intravenous midazolam for upper gastrointestinal endoscopy: A study of 800 consecutive cases relating dose to age and sex of patient. Br J Clin Pharmacol 1987; 23(2): 241-3.
33. Lerner AJ, Hedera P, Koss E, Stuckey J, Friedland RP. Delirium in alzheimer disease.
Alzheimer Dis Assoc Disord 1997; 11(1): 16-20.
34. ANTHONY K, PROCTER AW, Silverman A, MURPHY E. Mood and behaviour problems following the relocation of elderly patients with mental illness. Age Ageing 1987; 16(6): 355-65.
35. Goldberg A, Straus SE, Hamid JS, Wong CL. Room transfers and the risk of delirium incidence amongst hospitalized elderly medical patients: A case–control study. BMC
Geriatrics 2015; 15(1): 69.
36. Roberts G, Banerjee D, Mills G. The emergency evacuation of a geriatrics hospital in toxteth. Age Ageing 1982; 11(4): 244-8.
37. Mayo Clinic. Alzheimer’s and dementia care: 8 tips for doctors visits. 2019, Available from https://www.mayoclinic.org/healthy-lifestyle/caregivers/in-depth/alzheimers/ art-20047326 (05/22 2020).
38. Fiske J, Lewis D. The development of standards for domiciliary dental care services: Guidelines and recommendations. Gerodontology 2000; 17(2): 119-22.
39. Helgeson MJ, Smith BJ. Dental care in nursing homes: Guidelines for mobile and on‐site care. Special Care in Dentistry 1996; 16(4): 153-64.
40. Rech MA, Barbas B, Chaney W, Greenhalgh E, Turck C. When to pick the nose: Out-of-hospital and emergency department intranasal administration of medications. Ann
Emerg Med 2017; 70(2): 203-11.
41. Corrigan M, Wilson SS, Hampton J. Safety and efficacy of intranasally administered medications in the emergency department and prehospital settings. Am J Health Syst
Pharm 2015; 72(18): 1544-54.
42. Reves JG, Glass PSA, Lubarsky DA, McEvoy MD, Martinez-Ruiz R, eds. Intravenous anesthetics. In: Miller, R D, ed. Miller’s Anesthesia. Philadelphia, Pa.; Edinburgh: Elsevier Saunders, 2009; 719-756.
43. Colin P, Hannivoort LN, Eleveld DJ, et al. Dexmedetomidine pharmaco-kinetic–pharmacodynamic modelling in healthy volunteers: 1. influence of arousal on bispectral index and sedation. BJA: British Journal of Anaesthesia 2017; 119(2): 200-10. 44. Lodenius A, Ebberyd A, Hardemark Cedborg A, et al. Sedation with dexmedetomidine or
propofol impairs hypoxic control of breathing in healthy male volunteers: A nonblinded, randomized crossover study. Anesthesiology 2016; 125(4): 700-15.
45. Colin PJ, Hannivoort LN, Eleveld DJ, et al. Dexmedetomidine pharmacodynamics in healthy volunteers: 2. haemodynamic profile. Br J Anaesth 2017; 119(2): 211-20. 46. Su X, Meng ZT, Wu XH, et al. Dexmedetomidine for prevention of delirium in elderly
patients after non-cardiac surgery: A randomised, double-blind, placebo-controlled trial. Lancet 2016; 388(10054): 1893-902.
47. Anderson KJ, Kenny GNC, eds. Intravenous drugs for sedation: Target-controlled, patient-controlled and patient-maintained delivery. In: Absalom, A R, Mason, K P, eds.
Total Intravenous Anesthesia and Target controlled Infusions. Cham, Switzerland: Springer
International Publishing AG, 2017; 369-390.
48. Hill S. Pharmacokinetics of drug infusions. Continuing Education in Anaesthesia Critical Care & Pain 2004; 4(3): 76-80.
49. Eleveld DJ, ed. Propofol PK-PD. In: Absalom, A R, Mason, K P, eds. Total intravenous anesthesia and Target Controlled Infusions. Cham: Springer, 2017; 191-206.
134 135 References Chapter 11
50. Eleveld DJ, Colin P, Absalom AR, Struys MMRF. Pharmacokinetic-pharmacodynamic model for propofol for broad application in anaesthesia and sedation. Br J Anaesth 2018; 120(5): 942-59.
51. Wang D, Chen C, Chen J, et al. The use of propofol as a sedative agent in gastrointestinal
endoscopy: A meta-analysis. PLoS One 2013; 8(1): e53311.
52. Lewis SR, Nicholson A, Reed SS, Kenth JJ, Alderson P, Smith AF. Anaesthetic and sedative agents used for electrical cardioversion. Cochrane Database Syst Rev 2015;
(3):CD010824. doi(3): CD010824.
53. Garewal D, Powell S, Milan SJ, Nordmeyer J, Waikar P. Sedative techniques for endoscopic retrograde cholangiopancreatography. Cochrane Database Syst Rev 2012;
(6):CD007274. doi(6): CD007274.
54. Wang HY, Yang J, Yin W, Yang LH, Zhang WS. The sedative-hypnotic effects and safety of oral administrated propofol prodrugs hx0969w and fospropofol disodiun in comparison with propofol emulsion in rats. Sichuan Da Xue Xue Bao Yi Xue Ban 2015;
46(2): 214-7.
55. Jalili M, Bahreini M, Doosti-Irani A, Masoomi R, Arbab M, Mirfazaelian H. Ketamine-propofol combination (ketofol) vs Ketamine-propofol for procedural sedation and analgesia: Systematic review and meta-analysis. Am J Emerg Med 2016; 34(3): 558-69.
56. Ferguson I, Bell A, Treston G, New L, Ding M, Holdgate A. Propofol or ketofol for procedural sedation and analgesia in emergency medicine-the POKER study: A randomized double-blind clinical trial. Ann Emerg Med 2016; 68(5): 574,582.e1. 57. Kilic E, Demiriz B, Isikay N, Yildirim AE, Can S, Basmaci C. Alfentanil versus ketamine
combined with propofol for sedation during upper gastrointestinal system endoscopy in morbidly obese patients. Saudi Med J 2016; 37(11): 1191-5.
58. Singh SA, Prakash K, Sharma S, Dhakate G, Bhatia V. Comparison of propofol alone and in combination with ketamine or fentanyl for sedation in endoscopic ultrasonography.
Korean J Anesthesiol 2018; 71(1): 43-7.
59. Sruthi S, Mandal B, Rohit MK, Puri GD. Dexmedetomidine versus ketofol sedation for outpatient diagnostic transesophageal echocardiography: A randomized controlled study. Ann Card Anaesth 2018; 21(2): 143-50.
60. Weerink MAS, Struys MMRF, Hannivoort LN, Barends CRM, Absalom AR, Colin P. Clinical pharmacokinetics and pharmacodynamics of dexmedetomidine. Clin
Pharmacokinet 2017; 56(8): 893-913.
61. Barends CR, Absalom A, van Minnen B, Vissink A, Visser A. Dexmedetomidine versus midazolam in procedural sedation. A systematic review of efficacy and safety. PLoS One 2017; 12(1): e0169525.
62. Lu Z, Li W, Chen H, Qian Y. Efficacy of a dexmedetomidine-remifentanil combination compared with a midazolam-remifentanil combination for conscious sedation during therapeutic endoscopic retrograde cholangio-pancreatography: A prospective, randomized, single-blinded preliminary trial. Dig Dis Sci 2018;.
63. Kuang Y, Zhang RR, Pei Q, et al. Pharmacokinetic and pharmacodynamic study of
dexmedetomidine in elderly patients during spinal anesthesia. Int J Clin Pharmacol Ther 2015; 53(12): 1005-14.
64. Ko KH, Jun IJ, Lee S, Lim Y, Yoo B, Kim KM. Effective dose of dexmedetomidine to induce adequate sedation in elderly patients under spinal anesthesia. Korean J
Anesthesiol 2015; 68(6): 575-80.
65. Slupe AM, Minnier J, Raitt MH, Zarraga IGE, MacMurdy KS, Jessel PM. Dexmedetomidine sedation for paroxysmal supraventricular tachycardia ablation is not associated with alteration of arrhythmia inducibility. Anesth Analg 2018; 129(6): 1529-35.
66. Kim N, Yoo YC, Lee SK, Kim H, Ju HM, Min KT. Comparison of the efficacy and safety of sedation between dexmedetomidine-remifentanil and propofol-remifentanil during endoscopic submucosal dissection. World J Gastroenterol 2015; 21(12): 3671-8. 67. Mazanikov M, Udd M, Kylanpaa L, et al. Patient-controlled sedation with propofol and
remifentanil for ERCP: A randomized, controlled study. Gastrointest Endosc 2011; 73(2): 260-6.
68. Moerman AT, Herregods LL, De Vos MM, Mortier EP, Struys MM. Manual versus target-controlled infusion remifentanil administration in spontaneously breathing patients. Anesth Analg 2009; 108(3): 828-34.
69. LaPierre CD, Johnson KB, Randall BR, White JL, Egan TD. An exploration of remifentanil-propofol combinations that lead to a loss of response to esophageal instrumentation, a loss of responsiveness, and/or onset of intolerable ventilatory depression. Anesth Analg 2011; 113(3): 490-9.
70. Kisilewicz M, Rosenberg H, Vaillancourt C. Remifentanil for procedural sedation: A systematic review of the literature. Emerg Med J 2017; 34(5): 294-301.
71. Zhang J, Huang Y, Li Z, Li J, Liu K, Li C. Sedation and use of analgesics in endoscopic retrograde cholangiopancreatography: A double-blind comparison study of meperidine/midazolam, remifentanil/ midazolam, and remifentanil alone. Int J Clin
Pharmacol Ther 2016; 54(11): 872-9.
72. Wesolowski AM, Zaccagnino MP, Malapero RJ, Kaye AD, Urman RD. Remimazolam: Pharmacologic considerations and clinical role in anesthesiology. Pharmacotherapy 2016; 36(9): 1021-7.
73. Pambianco DJ, Borkett KM, Riff DS, et al. A phase IIb study comparing the safety
and efficacy of remimazolam and midazolam in patients undergoing colonoscopy.
Gastrointest Endosc 2016; 83(5): 984-92.
74. Rex DK, Bhandari R, Desta T, et al. A phase III study evaluating the efficacy and safety
of remimazolam (CNS 7056) compared with placebo and midazolam in patients undergoing colonoscopy. Gastrointest Endosc 2018; 88(3): 427,437.e6.
75. Forman SA. Clinical and molecular pharmacology of etomidate. Anesthesiology 2011;
114(3): 695-707.
76. Struys MMRF, Valk BI, Eleveld DJ, et al. A phase 1, single-center, double-blind,
placebo-controlled study in healthy subjects to assess the safety, tolerability, clinical effects, and pharmacokinetics-pharmacodynamics of intravenous cyclopropyl-methoxycarbonylmetomidate (ABP-700) after a single ascending bolus dose.
Anesthesiology 2017; 127(1): 20-35.
77. Jadad AR, Moore RA, Carroll D, et al. Assessing the quality of reports of randomized clinical trials: Is blinding necessary? Control Clin Trials 1996; 17(1): 1-12.
References Chapter 11
78. Moher D, Liberati A, Tetzlaff J, Altman DG, PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. PLoS Med 2009;
6(7): e1000097.
79. Frolich MA, Arabshahi A, Katholi C, Prasain J, Barnes S. Hemodynamic characteristics of midazolam, propofol, and dexmedetomidine in healthy volunteers. J Clin Anesth 2011; 23(3): 218-23.
80. Frolich MA, Zhang K, Ness TJ. Effect of sedation on pain perception. Anesthesiology 2013; 118(3): 611-21.
81. Hashiguchi K, Matsunaga H, Higuchi H, Miura S. Dexmedetomidine for sedation during upper gastrointestinal endoscopy. Dig Endosc 2008; 20(4): 178-83.
82. Muttu S, Liu EH, Ang SB, Chew PT, Lee TL, Ti LK. Comparison of dexmedetomidine and midazolam sedation for cataract surgery under topical anesthesia. J Cataract Refract
Surg 2005; 31(9): 1845-6.
83. Demiraran Y, Korkut E, Tamer A, et al. The comparison of dexmedetomidine and midazolam used for sedation of patients during upper endoscopy: A prospective, randomized study. Can J Gastroenterol 2007; 21(1): 25-9.
84. Liao W, Ma G, Su QG, Fang Y, Gu BC, Zou XM. Dexmedetomidine versus midazolam for conscious sedation in postoperative patients undergoing flexible bronchoscopy: A randomized study. J Int Med Res 2012; 40(4): 1371-80.
85. Alhashemi JA. Dexmedetomidine vs midazolam for monitored anaesthesia care during cataract surgery. Br J Anaesth 2006; 96(6): 722-6.
86. Apan A, Doganci N, Ergan A, Buyukkocak U. Bispectral index-guided intraoperative sedation with dexmedetomidine and midazolam infusion in outpatient cataract surgery.
Minerva Anestesiol 2009; 75(5): 239-44.
87. Cheung CW, Ying CL, Chiu WK, Wong GT, Ng KF, Irwin MG. A comparison of dexmedetomidine and midazolam for sedation in third molar surgery. Anaesthesia 2007;
62(11): 1132-8.
88. Fan TW, Ti LK, Islam I. Comparison of dexmedetomidine and midazolam for conscious sedation in dental surgery monitored by bispectral index. Br J Oral Maxillofac Surg 2013;
51(5): 428-33.
89. Kaya FN, Yavascaoglu B, Turker G, et al. Intravenous dexmedetomidine, but not
midazolam, prolongs bupivacaine spinal anesthesia. Can J Anaesth 2010; 57(1): 39-45. 90. Ustun Y, Gunduz M, Erdogan O, Benlidayi ME. Dexmedetomidine versus midazolam
in outpatient third molar surgery. J Oral Maxillofac Surg 2006; 64(9): 1353-8. 91. Mancuso CE, Tanzi MG, Gabay M. Paradoxical reactions to benzodiazepines: Literature
review and treatment options. Pharmacotherapy 2004; 24(9): 1177-85.
92. Wu XH, Cui F, Zhang C, et al. Low-dose dexmedetomidine improves sleep quality
pattern in elderly patients after noncardiac surgery in the intensive care unit: A pilot randomized controlled trial. Anesthesiology 2016; 125(5): 979-91.
93. Alexopoulou C, Kondili E, Diamantaki E, et al. Effects of dexmedetomidine on sleep quality in critically ill patients: A pilot study. Anesthesiology 2014; 121(4): 801-7.
94. Somma J, Donner A, Zomorodi K, et al. Population pharmacodynamics of midazolam
administered by target controlled infusion in SICU patients after CABG surgery.
Anesthesiology 1998; 89(6): 1430-43.
95. Zomorodi K, Donner A, Somma J, et al. Population pharmacokinetics of midazolam
administered by target controlled infusion for sedation following coronary artery bypass grafting. Anesthesiology 1998; 89(6): 1418-29.
96. Ebert TJ, Hall JE, Barney JA, Uhrich TD, Colinco MD. The effects of increasing plasma concentrations of dexmedetomidine in humans. Anesthesiology 2000; 93(2): 382-94. 97. Iirola T, Vilo S, Manner T, et al. Bioavailability of dexmedetomidine after intranasal
administration. Eur J Clin Pharmacol 2011; 67(8): 825-31.
98. Zhang X, Bai X, Zhang Q, Wang X, Lu L. The safety and efficacy of intranasal dexmedetomidine during electrochemotherapy for facial vascular malformation: A double-blind, randomized clinical trial. J Oral Maxillofac Surg 2013; 71(11): 1835-42. 99. Nooh N, Sheta SA, Abdullah WA, Abdelhalim AA. Intranasal atomized dexmedetomidine
for sedation during third molar extraction. Int J Oral Maxillofac Surg 2013; 42(7): 857-62. 100. Yuen VM, Hui TW, Irwin MG, et al. A randomised comparison of two intranasal
dexmedetomidine doses for premedication in children. Anaesthesia 2012; 67(11): 1210-6. 101. Mangoni AA, Jackson SH. Age-related changes in pharmacokinetics and
pharmacodynamics: Basic principles and practical applications. Br J Clin Pharmacol 2004; 57(1): 6-14.
102. European Medicines Agency. Summary of product characteristics:Dexdor (dexmedetomidine). 2012;.
103. Bjorkman S, Rigemar G, Idvall J. Pharmacokinetics of midazolam given as an intranasal spray to adult surgical patients. Br J Anaesth 1997; 79(5): 575-80.
104. Burstein AH, Modica R, Hatton M, Forrest A, Gengo FM. Pharmacokinetics and pharmacodynamics of midazolam after intranasal administration. J Clin Pharmacol 1997; 37(8): 711-8.
105. Li BL, Zhang N, Huang JX, et al. A comparison of intranasal dexmedetomidine for sedation in children administered either by atomiser or by drops. Anaesthesia 2016;
71(5): 522-8.
106. Yuen VM, Irwin MG, Hui TW, Yuen MK, Lee LH. A double-blind, crossover assessment of the sedative and analgesic effects of intranasal dexmedetomidine. Anesth Analg 2007; 105(2): 374-80.
107. Bijker JB, Persoon S, Peelen LM, et al. Intraoperative hypotension and perioperative
ischemic stroke after general surgery: A nested case-control study. Anesthesiology 2012; 116(3): 658-64.
108. Salmasi V, Maheshwari K, Yang D, et al. Relationship between intraoperative
hypotension, defined by either reduction from baseline or absolute thresholds, and acute kidney and myocardial injury after noncardiac surgery: A retrospective cohort analysis. Anesthesiology 2017; 126(1): 47-65.
109. Gu Q, Burt VL, Dillon CF, Yoon S. Trends in antihypertensive medication use and blood pressure control among united states adults with hypertension: The national health and nutrition examination survey, 2001 to 2010. Circulation 2012; 126(17): 2105-14.
138 139 References Chapter 11
110. Nelson LE, Lu J, Guo T, Saper CB, Franks NP, Maze M. The alpha2-adrenoceptor agonist dexmedetomidine converges on an endogenous sleep-promoting pathway to exert its sedative effects. Anesthesiology 2003; 98(2): 428-36.
111. Li A, Yuen VM, Goulay-Dufay S, et al. Pharmacokinetic and pharmacodynamic study of intranasal and intravenous dexmedetomidine. Br J Anaesth 2018; 120(5): 960-8. 112. Djupesland PG. Nasal drug delivery devices: Characteristics and performance in a
clinical perspective-a review. Drug Deliv Transl Res 2013; 3(1): 42-62.
113. Teleflex I. Using the LMA® MAD nasal™ intranasal mucosal atomization device 2013, Available from https://www.teleflex.com/en/usa/productAreas/ems/documents/AN_ ATM_MAD-Nasal-Usage_Guide_AI_2012-1528.pdf (10/8 2019).
114. Anttila M, Penttila J, Helminen A, Vuorilehto L, Scheinin H. Bioavailability of dexmedetomidine after extravascular doses in healthy subjects. Br J Clin Pharmacol 2003; 56(6): 691-3.
115. Borrat X, Valencia JF, Magrans R, et al. Sedation-analgesia with propofol and remifentanil: Concentrations required to avoid gag reflex in upper gastrointestinal endoscopy. Anesth Analg 2015; 121(1): 90-6.
116. Westerkamp AC, de Geus AF, Molenbuur B, et al. Comparing peri-operative complications of paediatric and adult anaesthesia: A retrospective cohort study of 81 267 cases. Eur J Anaesthesiol 2018; 35(4): 280-8.
117. Leslie K, Allen ML, Hessian EC, et al. Safety of sedation for gastrointestinal endoscopy in a group of university-affiliated hospitals: A prospective cohort study. Br J Anaesth 2017; 118(1): 90-9.
118. Chernik DA, Gillings D, Laine H, et al. Validity and reliability of the observer’s assessment of Alertness/Sedation scale: Study with intravenous midazolam. J Clin Psychopharmacol 1990; 10(4): 244-51.
119. Schnider TW, Minto CF, Shafer SL, et al. The influence of age on propofol pharmacodynamics. Anesthesiology 1999; 90(6): 1502-16.
120. Minto CF, Schnider TW, Egan TD, et al. Influence of age and gender on the pharmacokinetics and pharmacodynamics of remifentanil. I. model development.
Anesthesiology 1997; 86(1): 10-23.
121. McVay T, Fang JC, Taylor L, et al. Safety analysis of bariatric patients undergoing outpatient upper endoscopy with non-anesthesia administered propofol sedation.
Obes Surg 2017; 27(6): 1501-7.
122. Dundee JW, Robinson FP, McCollum JS, Patterson CC. Sensitivity to propofol in the elderly. Anaesthesia 1986; 41(5): 482-5.
123. Khoi CS, Wong JJ, Wang HC, Lu CW, Lin TY. Age correlates with hypotension during propofol-based anesthesia for endoscopic retrograde cholangiopancreatography. Acta
Anaesthesiol Taiwan 2015; 53(4): 131-4.
124. Chang A. StatsToDo : Sample size for rare events program. 2014, Available from https:// www.statstodo.com/SSizRareEvent_Pgm.php (06/06 2019).
125. Absalom AR, Glen JI, Zwart GJ, Schnider TW, Struys MM. Target-controlled infusion: A mature technology. Anesth Analg 2016; 122(1): 70-8.
126. Mertens MJ, Olofsen E, Engbers FH, Burm AG, Bovill JG, Vuyk J. Propofol reduces perioperative remifentanil requirements in a synergistic manner: Response surface modeling of perioperative remifentanil-propofol interactions. Anesthesiology 2003;
99(2): 347-59.
127. Moerman AT, Struys MM, Vereecke HE, Herregods LL, De Vos MM, Mortier EP. Remifentanil used to supplement propofol does not improve quality of sedation during spontaneous respiration. J Clin Anesth 2004; 16(4): 237-43.
128. Absalom AR, Mani V, De Smet T, Struys MM. Pharmacokinetic models for propofol--defining and illuminating the devil in the detail. Br J Anaesth 2009; 103(1): 26-37. 129. Sedgwick P, Greenwood N. Understanding the hawthorne effect. Bmj 2015; 351:
h4672.
130. Koers L, Eberl S, Cappon A, et al. Safety of moderate-to-deep sedation performed by sedation practitioners: A national prospective observational study. Eur J Anaesthesiol 2018; 35(9): 659-66.
131. Rignell L, Mikati M, Wertsen M, Hagglin C. Sedation with orally administered midazolam in elderly dental patients with major neurocognitive disorder. Gerodontology 2017;
34(3): 299-305.
132. Zorginstituut Nederland . Farmacotherapeutisch kompas:Midazolam. , Available from https://www.farmacotherapeutischkompas.nl/bladeren/preparaatteksten/m/ midazolam#eigenschappen (04/06 2020).
133. Knoester PD, Jonker DM, Van Der Hoeven RT, et al. Pharmacokinetics and pharmacodynamics of midazolam administered as a concentrated intranasal spray. A study in healthy volunteers. Br J Clin Pharmacol 2002; 53(5): 501-7.
134. Klotz U. Pharmacokinetics and drug metabolism in the elderly. Drug Metab Rev 2009;
41(2): 67-76.
135. Knape JT. Richtlijn sedatie en/of analgesie (psa) op locaties buiten de operatiekamer.
Igj 2012;: 45-78.
136. Hinkelbein J, Lamperti M, Akeson J, et al. European society of anaesthesiology and european board of anaesthesiology guidelines for procedural sedation and analgesia in adults. Eur J Anaesthesiol 2018; 35(1): 6-24.
137. Albrecht S, Ihmsen H, Hering W, et al. The effect of age on the pharmacokinetics and pharmacodynamics of midazolam. Clin Pharmacol Ther 1999; 65(6): 630-9.
138. Nordt SP, Clark RF. Midazolam: A review of therapeutic uses and toxicity. J Emerg Med 1997; 15(3): 357-65.
139. Vinik HR, Bradley EL,Jr, Kissin I. Midazolam-alfentanil synergism for anesthetic induction in patients. Anesth Analg 1989; 69(2): 213-7.
140. Ely EW, Truman B, Shintani A, et al. Monitoring sedation status over time in ICU patients: Reliability and validity of the richmond agitation-sedation scale (RASS). Jama 2003; 289(22): 2983-91.
141. Hardmeier M, Zimmermann R, Ruegg S, et al. Intranasal midazolam: Pharmacokinetics and pharmacodynamics assessed by quantitative EEG in healthy volunteers. Clin
Pharmacol Ther 2012; 91(5): 856-62.
References Chapter 11
142. Wermeling DP, Record KA, Archer SM, Rudy AC. A pharmacokinetic and pharmacodynamic study, in healthy volunteers, of a rapidly absorbed intranasal midazolam formulation. Epilepsy Res 2009; 83(2-3): 124-32.
143. Wermeling DP, Record KA, Kelly TH, Archer SM, Clinch T, Rudy AC. Pharmacokinetics and pharmacodynamics of a new intranasal midazolam formulation in healthy volunteers. Anesth Analg 2006; 103(2): 344,9, table of contents.
144. Berg AK, Myrvik MJ, Van Ess PJ. Pharmacokinetics, pharmacodynamics, and tolerability of USL261, midazolam nasal spray: Randomized study in healthy geriatric and non-geriatric adults. Epilepsy Behav 2017; 71(Pt A): 51-9.
145. Scholer SG, Schafer DF, Potter JF. The effect of age on the relative potency of midazolam and diazepam for sedation in upper gastrointestinal endoscopy. J Clin
Gastroenterol 1990; 12(2): 145-7.
146. Hall R, Zisook S. Paradoxical reactions to benzodiazepines. Br J Clin Pharmacol 1981;
11(S1): 99S-104S.
147. van Soest-Poortvliet MC, van der Steen, Jenny T, de Vet HC, Hertogh CM, Onwuteaka-Philipsen BD, Deliens LH. Factors related to establishing a comfort care goal in nursing home patients with dementia: A cohort study among family and professional caregivers.
J Palliat Med 2014; 17(12): 1317-27.
148. Bouwstra H, Smalbrugge M, Hertogh CM. Physician treatment orders in dutch nursing homes. Journal of the American Medical Directors Association 2015; 16(8): 715. e1,715. e5. 149. Hendriks SA, Smalbrugge M, Deliens L, et al. End of life treatment decisions in nursing home residents dying with dementia in the netherlands. Int J Geriatr Psychiatry 2017;
32(12): e43-9.
150. Mitchell SL, Teno JM, Kiely DK, et al. The clinical course of advanced dementia. N Engl
J Med 2009; 361(16): 1529-38.
151. Zwakhalen SM, Koopmans RT, Geels PJ, Berger MP, Hamers JP. The prevalence of pain in nursing home residents with dementia measured using an observational pain scale.
European Journal of Pain 2009; 13(1): 89-93.
152. Kruger J, Dunning D. Unskilled and unaware of it: How difficulties in recognizing one’s own incompetence lead to inflated self-assessments. J Pers Soc Psychol 1999; 77(6): 1121.
153. Barends CR, Absalom AR. Tied up in science: Unknotting an old anaesthetic problem.
Bmj 2013; 347: f6735.
154. Toonder M. De ombrenger, Eco-editie edn. Amsterdam: De Bezige Bij, 1971.
